| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
• Immutep, Inc. (NASDAQ:IMMP) shares increased by 65.45% to $1.82 during Wednesday's pre-market session.
• RTI Surgical Hldgs, Inc. (NASDAQ:RTIX) shares increased by 20.35% to $4.08.
• Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares moved upwards by 18.57% to $0.83. The most recent rating by H.C. Wainwright, on May 6, is at Neutral, with a price target of $5.
• Moderna, Inc. (NASDAQ:MRNA) shares increased by 16.87% to $87.70. The most recent rating by Brookline Capital, on Jul 13, is at Buy, with a price target of $95.
• TherapeuticsMD, Inc. (NASDAQ:TXMD) stock moved upwards by 16.10% to $1.73. According to the most recent rating by JP Morgan, on May 19, the current rating is at Neutral.
• VBI Vaccines, Inc. (NASDAQ:VBIV) stock moved upwards by 14.85% to $5.18.
• Novan, Inc. (NASDAQ:NOVN) shares rose 10.80% to $0.56.
• Fluidigm, Inc. (NASDAQ:FLDM) stock increased by 9.42% to $5.92.
• Orchard Therapeutics, Inc. (NASDAQ:ORTX) stock moved upwards by 9.37% to $5.60.
• ReWalk Robotics, Inc. (NASDAQ:RWLK) shares increased by 8.40% to $1.29.
• Zynex, Inc. (NASDAQ:ZYXI) stock decreased by 11.14% to $23.30 during Wednesday's pre-market session. According to the most recent rating by B. Riley FBR, on Jul 13, the current rating is at Neutral.
• Endologix, Inc. (NASDAQ:ELGX) stock declined 10.73% to $0.26. According to the most recent rating by BTIG, on May 12, the current rating is at Neutral.
• IMV, Inc. (NASDAQ:IMV) stock declined 8.86% to $4.22. The most recent rating by Wells Fargo, on May 18, is at Overweight, with a price target of $8.
• Cleveland BioLabs, Inc. (NASDAQ:CBLI) stock fell 8.26% to $3.
• Myos Rens Technology, Inc. (NASDAQ:MYOS) stock fell 7.76% to $1.19.
• Dynatronics, Inc. (NASDAQ:DYNT) stock declined 6.69% to $0.77. The most recent rating by Aegis Capital, on May 19, is at Buy, with a price target of $1.
• Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock declined 6.67% to $3.85. The most recent rating by JP Morgan, on May 27, is at Overweight, with a price target of $6.
• Dare Bioscience, Inc. (NASDAQ:DARE) shares fell 6.58% to $1.42. The most recent rating by Brookline Capital, on Apr 28, is at Buy, with a price target of $8.
• Vaxart, Inc. (NASDAQ:VXRT) shares declined 5.13% to $16.10. The most recent rating by B. Riley FBR, on Jul 13, is at Buy, with a price target of $22.
• INmune Bio, Inc. (NASDAQ:INMB) shares declined 5.08% to $14.95. The most recent rating by HC Wainwright & Co., on Jul 15, is at Buy, with a price target of $20.
Posted In: ACOR CBLI DARE DYNT ELGX FLDM IMMP IMV INMB MRNA MYOS NOVN ORTX RIGL RTIX RWLK TXMD VBIV VXRT ZYXI
